Nothing to Lose but Your Chains: Out-Partnering Part I
Lots of interest in out-partnering these days from Big Pharma – out-licensing, spin-offs, project financing (see in particular this IN VIVO analysis of Pfizer’s out-partnering strategy). But let’s eliminate a myth now. Out-partnering won’t raise lots of money for Big Pharma, even by selling tail-end products. Lilly’s entire out-licensing program –the industry’s most lucrative because it is the only one to exploit tail-end drugs- raised about $1 billion over 7-8 years. Now, that’s hardly chump c
Read full post here.
Business Banking Links
Key West Bank in Florida
Provides personal and business banking services in the Key West Florida area. Click here
Hingham Institution for Savings in Massachusetts
Community bank with branch locations in Hingham, Massachusetts. Click here
High Point Bank in North_Carolina
A community bank serving the greater High Point community of North Carolina. Click here